RAM Essential Services Property Fund has posted a $30.1 million FY2026 statutory loss as property values weakened, while its planned $218.6 million retail sale prepares the fund for a healthcare-focused reset. The transaction could reduce gearing to 16.8%, but FY2027 distribution guidance is below the latest payout and refinancing remains unfinished.
- $30.1 million statutory loss and $15.8 million normalised FFO
- Five retail assets sold unconditionally for approximately $218.6 million
- Projected post-transaction gearing of 16.8%, versus 43.53% at year-end
- FY2027 DPS forecast reduced to 3.6-3.8 cents
- NTA declined to $0.71 per security after valuation losses
Retail sale reshapes REP’s balance sheet
RAM Essential Services Property Fund (ASX:REP) is trying to turn a difficult year into a cleaner starting point. Its unconditional sale of five retail assets for approximately $218.6 million is expected to cut gearing from 43.53% at 30 June 2026 to 16.8%, assuming the transaction settles and all net proceeds are used to repay debt. REP will retain a 10% interest in the acquiring Forest Retail JV fund rather than exiting the retail assets entirely.
The properties are Coomera Square, Springfield Fair, Coles Rutherford, Keppel Bay Plaza and Mowbray Marketplace, with settlement expected in the second quarter of FY2027. REP says the disposal advances its planned transition to a specialist healthcare REIT, while the retained interest is intended to preserve some retail income exposure. The transaction carries no acquisition or divestment fee for the fund.
The strategy builds on REP’s earlier asset recycling, but the latest disposal is materially more consequential because it addresses the fund’s debt position. The annual report says preliminary lender support has been received for refinancing, including an indicative offer to extend the facility for two years. That remains a future financing arrangement, not a completed refinancing.
Losses reflect property valuations and weaker funds from operations
REP reported a statutory loss of $30.075 million, compared with a restated loss of $10.126 million a year earlier. The result included a $38.418 million unrealised loss on investment property revaluations. The weighted average capitalisation rate rose to 6.20% in the portfolio presentation, while the financial report records a 6.29% rate for investment properties after classification adjustments.
Normalised funds from operations fell to $15.762 million, or 3.15 cents per security, from $24.505 million. Yet distributions totalled 4.55 cents per security, producing a reported normalised FFO payout ratio of 144.6%. Net tangible assets dropped to $0.71 per security from $0.81, with the fund stating that downward property revaluations were the primary reason.
Healthcare portfolio offers stronger income characteristics
Operationally, the portfolio remained relatively firm. Like-for-like recurring property income increased 4.4% to $37.9 million, leasing spreads were positive across 21 deals, and occupancy was reported at 97% in the portfolio highlights. REP says the post-sale portfolio will have a WALE of more than eight years, compared with 6.8 years at 30 June, and a greater proportion of healthcare income, net leases and fixed or CPI-linked rent reviews.
Those characteristics are the central investment case for the pivot: longer healthcare leases, annual escalators and predominantly triple-net structures can support recurring income and limit exposure to property outgoings. They do not, however, remove valuation sensitivity. REP’s own sensitivity analysis indicates that a 25-basis-point increase in capitalisation rates would reduce investment property fair value by about $15.9 million, while medical property values carry the larger sensitivity in the broader portfolio analysis.
Lower FY2027 payout points to transition costs
The manager is forecasting FY2027 distributions of 3.6 to 3.8 cents per security, below the 4.55 cents paid for FY2026. Based on the reference price used in the report, that implies an estimated yield of 8.5% to 9%, with a target FFO payout ratio of 90% to 100% and approximately 90% of distributions expected to be tax deferred.
The immediate tension is clear: the sale may deliver a much less leveraged fund, but asset disposals also change the income base and leave the next distribution below the latest annual payout. REP’s $340 million syndicated debt facility matures in January 2027, and $289.3 million was drawn at year-end. The annual report says the directors found no material going-concern uncertainty after considering the expected sale proceeds, forecast covenant compliance, liquidity and preliminary refinancing discussions. The decisive evidence will come when settlement, debt repayment and refinancing terms are completed.
Bottom Line?
REP is closer to a lower-geared healthcare vehicle, but the transition still has to convert a prospective balance-sheet improvement into sustainable cash distributions.
Questions in the middle?
- Will the five-asset sale settle on schedule and how much of the cash proceeds will ultimately repay debt?
- What refinancing terms will REP secure before the existing syndicated facility matures in January 2027?
- Can healthcare leasing growth offset the lower income base implied by the FY2027 distribution forecast?